Sprint Bioscience AB Income Statement

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Operating Revenue	153.06	167.17	65.64	50.49	0.08	35.11
Other Revenue	0.05	0.22	0.5	1.2	-	-0.09
Revenue	153.1	167.39	66.14	51.69	0.08	35.03
Revenue Growth (YoY)	144.56%	153.07%	27.97%	62171.08%	-99.76%	82.48%
Cost of Revenue	9.48	13.08	28.34	8.7	12.93	10.44
Gross Profit	143.63	154.31	37.8	42.99	-12.85	24.59
Selling, General & Admin	54.78	55.69	56.28	45.07	47.44	49.47
Other Operating Expenses	-0.48	-	-0.67	-1.21	-0.29	-
Operating Expenses	55.38	56.76	56.57	44.31	47.77	50.06
Operating Income	88.24	97.55	-18.77	-1.32	-60.62	-25.47
Interest Expense	-	-0.42	-0.04	-	-0	-0.27
Interest & Investment Income	0.93	0.65	1.32	0.79	-	-
Currency Exchange Gain (Loss)	-6.04	-6.04	-0.79	0.09	0.45	0.69
Other Non Operating Income (Expenses)	1.36	-	-0	-	-0	-0.04
EBT Excluding Unusual Items	84.49	91.74	-18.28	-0.44	-60.17	-25.08
Pretax Income	84.49	91.74	-18.28	-0.44	-60.17	-25.08
Net Income	84.49	91.74	-18.28	-0.44	-60.17	-25.08
Net Income to Common	84.49	91.74	-18.28	-0.44	-60.17	-25.08
Shares Outstanding (Basic)	102	93	70	70	42	29
Shares Outstanding (Diluted)	102	93	70	70	42	29
Shares Change (YoY)	45.41%	32.63%	0.01%	65.98%	45.85%	71.85%
EPS (Basic)	0.83	0.99	-0.26	-0.01	-1.43	-0.87
EPS (Diluted)	0.82	0.98	-0.26	-0.01	-1.43	-0.87
Free Cash Flow	69.7	83.44	-24.65	20.42	-59.05	-42.82
Free Cash Flow Per Share	0.69	0.90	-0.35	0.29	-1.40	-1.49
Gross Margin	93.81%	92.19%	57.16%	83.17%	-	70.21%
Operating Margin	57.64%	58.28%	-28.37%	-2.56%	-73031.32%	-72.70%
Profit Margin	55.18%	54.81%	-27.63%	-0.85%	-72493.98%	-71.61%
Free Cash Flow Margin	45.52%	49.85%	-37.27%	39.50%	-71149.40%	-122.26%
EBITDA	89.32	98.62	-17.81	-0.88	-60	-24.88
EBITDA Margin	58.34%	58.92%	-26.93%	-1.70%	-	-71.02%
D&A For EBITDA	1.08	1.07	0.96	0.45	0.62	0.59
EBIT	88.24	97.55	-18.77	-1.32	-60.62	-25.47
EBIT Margin	57.64%	58.28%	-28.37%	-2.56%	-	-72.70%
Revenue as Reported	153.37	167.65	67.44	54.32	0.45	35.07

Source: S&P Global Market Intelligence. Standard template. Financial Sources.